Go to main text Go to main menu

News

ORTHOTECH and BIOBIJOU sign a supply agreement for acellular allogeneic dermis products.

2026. 02. 20
Date
2026. 02. 20 (Fri)

ORTHOTECH and BIOBIJOU  Sign Supply Agreement for Acellular Allogeneic Dermis Products, November 13, 2025


A supply agreement was signed with Biobijou for products based on acellular allogeneic dermis (hADM), alongside the joint launch of the regenerative solution brand ‘Cellivion.’ By applying the low-temperature alloPELT process, the extracellular matrix (ECM) structure and key proteins are preserved, thereby enhancing tissue regeneration efficiency. The two companies have also established a collaborative system to ensure stable supply and continuous quality advancement. Leveraging a global distribution network, they plan to expand their regenerative therapy portfolio while strengthening the competitiveness and market presence of Korea’s regenerative bio industry.



Recent Products